TABLE 2.
GA before (days) | GA after (days) | Duration on AP (hours) | Weight before (g) | Weight after (g) | Δ Weight (g) | Sex (M, F) | Reason for termination | Oxygenator |
---|---|---|---|---|---|---|---|---|
93 | 95 | 36.7 | 390 | 450 | 60 | F | Fetal movement occluded UV flow | P |
98 | 98 | 3.4 | 450 | 450 | E | M | Heart failure | P |
100 | 101 | 14.1 | 505 | NA | NA | M | Mechanical failure (pump) | P |
100 | 101 | 15.1 | 520 | 620 | E | M | Heart failure | Q |
100 | 102 | 49.4 | 590 | 750 | 160 | F | Heart failure | P |
101 | 104 | 70.0 | 762 | 1190 | 428 | M | Mechanical failure (oxygenator) | Q |
102 | 109 | 177.8 | 480 | 1176 | 696 | M | Hydrops, cardiac dysfunction | P |
105 | 108 | 68.5 | 610 | NA | NA | NA | Mechanical failure (oxygenator) | P |
105 | 105 | 17.1 | 676 | NA | E | M | Fetal movement occluded UV flow | P |
105 | 108 | 53.5 | 690 | NA | NA | M | Fetal movement occluded UV flow | P |
105 | 105 | 4.2 | 730 | 730 | E | M | Thrombosis development in circuit | P |
105 | 106 | 21.1 | 780 | 879 | E | M | Equipment failure (sweep-gas supply) | P |
107 | 110 | 72.5 | 820 | 876 | 56 | F | Fetal movement occluded UV flow | P |
102 ± 4 | 104 ± 4 | 46.4 ± 46.8 | 616 ± 139 | 792 ± 272 (n = 9) | 280 ± 277 (n = 5) |
The bold letters represent MEAN ± SD.
NA, not available; M, male; F, female; GA, gestational age; E, excluded from Δ weight analysis; P, Paragon neonatal commercially available ECMO oxygenator; Q, Quadrox-I commercially available bypass oxygenator.